New methods in coagulation (Q40219568)

18 September 2017

1 reference

title

New methods in coagulation (English)

1 reference

18 September 2017

Triplett DA

1

1 reference

18 September 2017

1 January 1981

1 reference

Critical Reviews in Clinical Laboratory Sciences

18 September 2017

1 reference

18 September 2017

15

1 reference

18 September 2017

1

1 reference

18 September 2017

25-84

1 reference

Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue

18 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Anticoagulant properties of bovine plasma protein C following activation by thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Quantitation of factor VIII related antigen (FVIIIRAG) using a laser nephelometer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunoradiometric measurement of the factor VIII procoagulant antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Dysfibrinogenemia associated with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Acquired dysfibrinogenaemia in acute and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Dysfibrinogenaemia and liver cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Activation of prothrombin Barcelona evidence for active high molecular weight intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The effect of several viper venoms on prothrombin Padua

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Prothrombin Brussels, a new congenital defective protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Combined Functional and Immunochemical Analysis of Normal and Abnormal Human Factor X

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Active and Inactive Factor VII in Dubin-Johnson Syndrome with Factor-VII Deficiency, Hereditary Factor-VII Deficiency and on Coumadin Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor VII activity and cross reacting material in normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Two Types of Haemophilia (A+and A−): A Study of 48 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A new simple assay for factor VIII related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Rapid Assay for von Willebrand Factor Activity Using Formalin-fixed Platelets and Microtitration Technic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

An Improved Assay for von Willebrand Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

'Autosomal haemophilia': a variant of von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A variant of factor 8 related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Evidence for a qualitative defect in factor-VIII-related antigen in von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Studies on the altered electrophoretic type of the factor VIII related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Von Willebrand's disease: combined qualitative and quantitative abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Von Willebrand's disease associated with thrombocytopenia and a fast migrating factor VIII related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

“Variants” of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Two Populations of Factor VIII-Related Antigen in a Family with von Willebrand's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The Factor VIII Abnormality in Severe von Willebrand's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Further studies on the factor VIII of a patient with a variant form of von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8().

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor VIII antigen pre-peak

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

THE THROMBOTEST REAGENT AND CHRISTMAS DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Haemophilia Bm: a new type of factor-IX deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Studies on the inheritance and nature of hemophilia BM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Comparison of precipitating antisera against normal and abnormal factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunologic studies of factor IX (christmas factor) I. Counterimmunoelectrophoresis method for factor IX antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

An investigation of three patients with Christmas disease due to an abnormal type of factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The Genetic Heterogeneity of Hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Cross-reacting material in genetic variants of haemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

An immunological investigation of hemophilia B with a tentative classification of the disease into five variants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunological Heterogeneity of Haemophilia B: a Multicentre Study of 98 Kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A Genetic Variant of Factor IX with Decreased Capacity for Ca2+Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Hemophilia B+ or BM. first case reported in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Detection of carriers of haemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Laboratory Prediction of the Carrier State in Hemophilia B: Role of Replication of Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Studies of human factor IX by a high-titred sheep antiserum against factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Multiple forms of human factor IX in chromatography and isoelectric focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Combined Deficiency of Factor V and Factor VIII: Report of a Family and Genetic Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Abnormal factor IX during anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Effect of exercise on the level of antihaemophilic globulin in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Effect of corticosteroids on factor VIII level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Increased Factor VIII Levels in Suspected Carriers of Hemophilia A Taking Contraceptives by Mouth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

In vivo and in vitro effects of thrombin and plasmin on human factor VIII (ahf)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Bleeding in renal failure: is von Willebrand factor implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor VIII and chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Modification of factor VIII complex properties in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Increased von Willebrand factor in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Three Approaches to the Radioimmunoassay of Human β-Thromboglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

beta-Thromboglobulin test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Plasma levels of platelet factor 4 measured by radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Studies on the Liberation of β-Thromboglobulin from Human Platelets in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

New rapid method for diagnosis of deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Beta-thromboglobulin levels and oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Plama-thromboglobulin concentrations in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Elevated Plasma <i>β</i>-Thromboglobulin Levels in Multiple Myeloma and in Polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Platelet and Plasma β Thromboglobulin in Mycloproliferative Syndromes and Secondary Thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Evidence for the Platelet Specificity of β-Thromboglobulin and Studies on its Plasma Concentration in Healthy Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Plasma heparin neutralizing activity in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Radioimmunoassay of Fibrinopeptides in Relation to Intravascular Coagulation and Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunological assay for a carboxyterminal peptide of the fibrinogen Aα-chain in normal and pathological human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Measurement of fibrinopeptide A in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Quantitation of thrombin-antithrombin III complexes in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Radioimmunoassay of fibrinogen-fibrin degradation products: Assay for fragment E-related neoantigen -methodological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

The measurement of thrombin in clotting blood by radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A sensitive fluorescent assay for determining α2-plasmin inhibitor using a synthetic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Assay of α2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Role of a Buried Acid Group in the Mechanism of Action of Chymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

New Fluorogenic Substrates for α-Thrombin, Factor Xa, Kallikreins, and Urokinase1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Fluorescent substrate assay for antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Assay of factor Xa in intact plasma as a possible method for early diagnosis of intravascular coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A new sensitive and highly specific chromogenic peptide substrate for factor Xa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Amplification of color yield of chromogenic substrates using p-dimethylaminocinnamaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Assay for plasma heparin using a synthetic peptide substrate for thrombin: introduction of the fluorophore aminoisophthalic acid, dimethyl ester

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

A fluorescent substrate assay for plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Heparin cofactor activity measured with an amidolytic method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Evaluation of an amidolytic heparin cofactor assay method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Problems in the assay of thrombin using synthetic peptides as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Abnormal factor X (factor X Friuli) coagulation disorder. The heterozygote population. A study of 57 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Factor XIII deficiency. A family study by measurement of factor XIII subunits A and S.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

Structure of N-terminal Fragments of Fibrinogen and Specificity of Thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368109105868

10.3109/10408368109105868

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_zjllzhg37jgffcxaesn53lhgym

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zjllzhg37jgffcxaesn53lhgym

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

6459909

1 reference

PubMed ID

6459909